173 related articles for article (PubMed ID: 37740222)
41. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA
Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549
[TBL] [Abstract][Full Text] [Related]
42. Ischemic preconditioning involves dual cardio-protective axes with p38MAPK as upstream target.
Nagy N; Shiroto K; Malik G; Huang CK; Gaestel M; Abdellatif M; Tosaki A; Maulik N; Das DK
J Mol Cell Cardiol; 2007 May; 42(5):981-90. PubMed ID: 17397860
[TBL] [Abstract][Full Text] [Related]
43. The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents.
Lin MZ; Marzec KA; Martin JL; Baxter RC
Oncogene; 2014 Jan; 33(1):85-96. PubMed ID: 23178489
[TBL] [Abstract][Full Text] [Related]
44. Individual dose and scheduling determine the efficacy of combining cytotoxic anticancer agents with a kinase inhibitor in non-small-cell lung cancer.
Meiler J; Guyot M; Hoffarth S; Wesarg E; Höhn Y; Breitenbuecher F; Schuler M
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1385-94. PubMed ID: 22488173
[TBL] [Abstract][Full Text] [Related]
45. DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization.
Reinhardt HC; Hasskamp P; Schmedding I; Morandell S; van Vugt MA; Wang X; Linding R; Ong SE; Weaver D; Carr SA; Yaffe MB
Mol Cell; 2010 Oct; 40(1):34-49. PubMed ID: 20932473
[TBL] [Abstract][Full Text] [Related]
46. Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro.
Hahn SM; Liebmann JE; Cook J; Fisher J; Goldspiel B; Venzon D; Mitchell JB; Kaufman D
Cancer; 1993 Nov; 72(9):2705-11. PubMed ID: 8104682
[TBL] [Abstract][Full Text] [Related]
47. Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to edelfosine-induced cell death and different cell line-specific responses to edelfosine treatment.
Shafer SH; Williams CL
Int J Oncol; 2003 Aug; 23(2):389-400. PubMed ID: 12851688
[TBL] [Abstract][Full Text] [Related]
48. Rice callus suspension culture inhibits growth of cell lines of multiple cancer types and induces apoptosis in lung cancer cell line.
Rahman N; Dhadi SR; Deshpande A; Ramakrishna W
BMC Complement Altern Med; 2016 Nov; 16(1):427. PubMed ID: 27806706
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy.
Krystal GW; Sulanke G; Litz J
Mol Cancer Ther; 2002 Sep; 1(11):913-22. PubMed ID: 12481412
[TBL] [Abstract][Full Text] [Related]
50. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.
Gan PP; Pasquier E; Kavallaris M
Cancer Res; 2007 Oct; 67(19):9356-63. PubMed ID: 17909044
[TBL] [Abstract][Full Text] [Related]
51. p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.
Reinhardt HC; Aslanian AS; Lees JA; Yaffe MB
Cancer Cell; 2007 Feb; 11(2):175-89. PubMed ID: 17292828
[TBL] [Abstract][Full Text] [Related]
52. Signaling crosstalk of FHIT, CHK2 and p38 in etoposide induced growth inhibition in MCF-7 cells.
Mir Mohammadrezaei F; Mohseni kouchesfehani H; Montazeri H; Gharghabi M; Ostad SN; Ghahremani MH
Cell Signal; 2013 Jan; 25(1):126-32. PubMed ID: 23000346
[TBL] [Abstract][Full Text] [Related]
53. Global proteomic profiling identifies etoposide chemoresistance markers in non-small cell lung carcinoma.
Paul D; Chanukuppa V; Reddy PJ; Taunk K; Adhav R; Srivastava S; Santra MK; Rapole S
J Proteomics; 2016 Apr; 138():95-105. PubMed ID: 26898345
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of MDM2 inhibitor MI-219 against lung cancer cells alone or in combination with MDM2 knockdown, a XIAP inhibitor or etoposide.
Zheng M; Yang J; Xu X; Sebolt JT; Wang S; Sun Y
Anticancer Res; 2010 Sep; 30(9):3321-31. PubMed ID: 20944104
[TBL] [Abstract][Full Text] [Related]
55. Schedule-dependent synergy of histone deacetylase inhibitors with DNA damaging agents in small cell lung cancer.
Luchenko VL; Salcido CD; Zhang Y; Agama K; Komlodi-Pasztor E; Murphy RF; Giaccone G; Pommier Y; Bates SE; Varticovski L
Cell Cycle; 2011 Sep; 10(18):3119-28. PubMed ID: 21900747
[TBL] [Abstract][Full Text] [Related]
56. A novel carbazole derivative, MHY407, sensitizes cancer cells to doxorubicin-, etoposide-, and radiation treatment via DNA damage.
Yoon S; Kim JH; Lee YJ; Ahn MY; Choi G; Kim WK; Yang Z; Lee HJ; Moon HR; Kim HS
Eur J Pharmacol; 2012 Dec; 697(1-3):24-31. PubMed ID: 23085270
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss.
Murali B; Ren Q; Luo X; Faget DV; Wang C; Johnson RM; Gruosso T; Flanagan KC; Fu Y; Leahy K; Alspach E; Su X; Ross MH; Burnette B; Weilbaecher KN; Park M; Mbalaviele G; Monahan JB; Stewart SA
Cancer Res; 2018 Oct; 78(19):5618-5630. PubMed ID: 30093561
[TBL] [Abstract][Full Text] [Related]
58. Downregulation of PARP1 transcription by CDK4/6 inhibitors sensitizes human lung cancer cells to anticancer drug-induced death by impairing OGG1-dependent base excision repair.
Tempka D; Tokarz P; Chmielewska K; Kluska M; Pietrzak J; Rygielska Ż; Virág L; Robaszkiewicz A
Redox Biol; 2018 May; 15():316-326. PubMed ID: 29306194
[TBL] [Abstract][Full Text] [Related]
59. Oral etoposide in small cell lung cancer.
Carney DN; Keane M; Grogan L
Semin Oncol; 1992 Dec; 19(6 Suppl 14):40-4. PubMed ID: 1336899
[TBL] [Abstract][Full Text] [Related]
60. Comparison of DNA cleavage induced by etoposide and doxorubicin in two human small-cell lung cancer lines with different sensitivities to topoisomerase II inhibitors.
Binaschi M; Capranico G; De Isabella P; Mariani M; Supino R; Tinelli S; Zunino F
Int J Cancer; 1990 Feb; 45(2):347-52. PubMed ID: 2154411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
